|
    AXDX U.S.: Nasdaq

    Accelerate Diagnostics Inc.

    AXDXUS
    After Hours
    Back To Top
    Last Updated: Jul 26, 2021 4:44 p.m. EDT Delayed quote

    $ 7.29

    0.00 0.00%
    After Hours Volume: 2.27K
    Close Chg Chg %
    $7.29 0.22 3.11%
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 98.95K 65 Day Avg: 184.93K
    54% vs Avg
    7.04 Day Range 7.41
    6.44 52 Week Range 17.82

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    AXDX Overview

    Performance

    5 Day
    • 10.29%
    1 Month
    • -14.94%
    3 Month
    • -12.69%
    YTD
    • -3.83%
    1 Year
    • -51.59%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 5 Full Ratings

    Recent News

    • eLesor
    • Dow Jones

    Accelerate Diagnostics Launches New Accelerate PhenoTest BC Kit in U.S.

    Accelerate Diagnostics downgraded to underweight from neutral at J.P. Morgan

    Accelerate Diagnostics stock price target cut to $16 from $25 at J.P. Morgan

    Accelerate Diagnostics downgraded to neutral from overweight at J.P. Morgan

    Read full story

    5 stocks to watch

    Accelerate Diagnostics started at overweight with $17 stock price target at J.P. Morgan

    Read full story

    10 stocks that are pushing the Nasdaq to 5,000

    • Other News
    • Press Releases

    Up 6% in June, Is Accelerate Diagnostics a Good Buy Now?

    on Motley Fool

    New Strong Sell Stocks for June 2nd

    on Zacks.com

    New Strong Sell Stocks for May 20th

    on Zacks.com

    New Strong Sell Stocks for May 14th

    on Zacks.com

    Accelerate Diagnostics (AXDX) Receives a Hold from BTIG

    on SmarterAnalyst

    Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates

    on Zacks.com

    Will Accelerate Diagnostics (AXDX) Report Negative Q1 Earnings? What You Should Know

    on Zacks.com

    2 Great Stocks Under $10 per Share

    on Motley Fool

    US Stocks Close Mostly Higher Monday

    on GuruFocus.com

    Will Accelerate Diagnostics (AXDX) Report Negative Earnings Next Week? What You Should Know

    on Zacks.com

    Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    on Zacks.com

    Accelerate Diagnostics (AXDX) Moves to Strong Buy: Rationale Behind the Upgrade

    on Zacks.com

    How Accelerate Diagnostics (AXDX) Stock Stands Out in a Strong Industry

    on Zacks.com

    Will Accelerate Diagnostics (AXDX) Report Negative Earnings Next Week? What You Should Know

    on Zacks.com

    Accelerate Diagnostics (AXDX) Moves to Buy: Rationale Behind the Upgrade

    on Zacks.com

    Accelerate Diagnostics Inc.

    Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.

    Competitors

    Name Chg % Market Cap
    Bruker Corp. -1.81% $12.48B
    Thermo Fisher Scientific Inc. -0.59% $209.19B
    PerkinElmer Inc. 4.73% $18.42B
    Becton Dickinson & Co. -0.66% $73.02B
    Bio-Rad Laboratories Inc. Cl A 0.39% $20.39B
    NanoString Technologies Inc. -0.29% $2.77B
    Competitor Data Provided ByCapital Cube Logo